LEADER 00000nam  2200000Ia 4500 
001    340722270    
003    OCoLC 
005    20090522092759.0 
006    m        d f       
007    cr an||||||||| 
008    090522s2004    mdu     s    f000 0 eng d 
040    GPO|cGPO|dMvI 
074    0499-T-02 (online) 
086 0  HE 20.4802:IN 2/2 
245 00 Guidance for industry|h[electronic resource] :
       |bindependent consultants for biotechnology clinical trial
       protocols. 
246 30 Independent consultants for biotechnology clinical trial 
       protocols. 
260    Rockville, MD :|bU.S. Dept. of Health and Human Services, 
       Food and Drug Administration, Center for Biologics 
       Evaluation and Research :|bCenter for Drug Evaluation and 
       Research,|c[2004] 
300    i, 4 p. :|bdigital, PDF file. 
500    Title from PDF title page (viewed on May 22, 2009). 
500    "August 2004". 
538    Mode of access: Internet at the FDA CBER web site. Address
       as of 5/22/09: http://www.fda.gov/cber/gdlns/bioclin.pdf  
       ; current access is available via PURL. 
650  0 Consultants|xGovernment policy|zUnited States. 
650  0 Clinical trials|xGovernment policy|zUnited States. 
650  0 Medical protocols|xGovernment policy|zUnited States. 
710 2  Center for Biologics Evaluation and Research (U.S.) 
710 2  Center for Drug Evaluation and Research (U.S.) 
856 40 |uhttp://purl.access.gpo.gov/GPO/LPS112997 
LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE